Table 2. Primary and Secondary End Points.
| End point | No. (%) | RR (95% CI) | |
|---|---|---|---|
| EVT with standard care (n = 33) | Standard care only (n = 34) | ||
| Primary | |||
| mRS score 0-1 at 12 mo | 22 (67) | 23 (68) | 0.99 (0.71-1.38) |
| Secondary | |||
| mRS score 0-2 at 12 mo | 28 (85) | 28 (82) | 1.03 (0.83-1.27) |
| mRS score at 12 mo, median (IQR) | 1 (0-2) | 1 (0-2) | 0.90 (0.38-2.14)a |
| mRS score 0-1 at 6 mo | 18 (55) | 14 (41) | 1.32 (0.80-2.20) |
| mRS score 0-2 at 6 mo | 27 (82) | 29 (85) | 0.96 (0.78-1.19) |
| Surgical intervention related to CVT | 4 (12) | 4 (12) | 1.03 (0.28-3.78) |
| Complete recanalization | |||
| Superior sagittal sinus at 6-12 mob | 22 (79) | 15 (52) | 1.52 (1.02-2.27) |
| Straight sinus at 6 moc | 27 (96) | 24 (86) | 1.13 (0.95-1.33) |
Abbreviations: CVT, cerebral venous thrombosis; EVT, endovascular treatment; IQR, interquartile range; mRS, modified Rankin Scale (score range: 0-6, with 0 indicating no symptoms and 6 indicating death); RR, relative risk.
a
Common odds ratio, not RR ratio, was given for the median mRS score at 12 months.
b
Evaluable for 28 patients randomized to EVT and 29 patients randomized to control.
c
Evaluable for 28 patients randomized to EVT and 28 patients randomized to control.